Cooperation.
For every new treatment that comes to market, hundreds of important discoveries are made along the way that contribute to science, medicine, and technology. For these contributions and many others, ND Pharma provides several opportunities for our scientists to be recognized and rewarded for excellent work.
Research at ND Pharma is ongoing, and with some of the best talent in the health care industry, our scientists and research cooperators regularly publish key findings in peer-reviewed medical and scientific journals. We also attends key medical and industry meetings throughout the year, where our scientists present their published findings and research in front of their peers.
We are grateful to those members on the ND Science team who have demonstrated their commitment to science, technology, and medicine. Their commitment, intellect, and innovative thinking have the power to advance clinical discoveries and improve the way we live.
Corporate Research Agreements and collaborations
While most of our discovery and development programs are developed internally - making ND Pharma quite unique in the industry - we are continuously looking for partnerships and superior technology that complement our business model. Some of our current collaborations include:
ND PHARMA is constantly seeking for partnerships and associations in everyone of the fields that we developed and where we conduct business. These partnerships and associations include academic institutions, research centers, other corporations and individuals.
Partnering is a key component of our business strategy, as we consider every possibility to develop and partner successful programs to pharmaceutical, biotechnology and medical device products, services, components and companies.
We welcome enquiries from other companies wishing to discuss any partnering opportunity with us.
In-Licensing is another source of business for us. We welcome contacts from academic institutions, inventors, researchers and other operatori within the industry from biotech, pharma, or other related fields. Our prime filter criteria is based on a three step consideration initial process:
Working with corporate partners.
ND PHARMA focuses in developing pioneering and novel products, drugs, and molecules in specialist areas, from food to pharma and therapy where there is a distinct lack of existing solutions, with emphasis in personalized medicine and novel therapies in the field of Regenerative Medicine, Stem Cell Advancement and other like nutrition.
Since our foundation, our research strategy has been to work closely to different "first line" institutions and operational centers that conduct investigation for us, under guidance and supervision of our clinical & scientific director´s team. These institutional cooperation enables us to access innovative research and cutting edge discovery with substantial added value and immediate application to the developments under a relatively optimized costs. ND Pharma maintains exclusive tights to all the intellectual property assets generated under such cooperation agreement and the research and development conducted.
Our market strategy, specially referred to pharmaceutical and therapeutic industry is to license our assets to leading international corporations and/or other industry operators (nutrition, food, feed, etc.) that are interested in further development and commercialization of some molecules and/or drugs.
We offer distinctive solutions to a number of unmet clinical conditions, diseases and pathologies.
Business development and clients.
ND PHARMA entered into some important and interesting corporate deals with major companies worldwide. So some of the "multi-billion dollar" corporations are now within our client list. Specifically within the food and nutrition industry we developed product innovation and license deals with the major producers of drinks, sodas, sport beverages and related industry sectors in the field, helping them to improve the quality, health and nutrition properties of their own products, both existing and other to appear. Other huge market corporations we work for include desert and ice-cream industry, infant nutrition labs and manufacturers, and large corporation of general foods.
ND PHARMA also supply with active principles, transformation and refining of molecules and own developments to pharmaceutical industry including some of the "top ten" Pharma Corporations, with presence all around the world.
Operations.
ND PHARMA operations are conducted worldwide. We are proud of having business partners worldwide and operate in 5 continents.
Research at ND Pharma is ongoing, and with some of the best talent in the health care industry, our scientists and research cooperators regularly publish key findings in peer-reviewed medical and scientific journals. We also attends key medical and industry meetings throughout the year, where our scientists present their published findings and research in front of their peers.
We are grateful to those members on the ND Science team who have demonstrated their commitment to science, technology, and medicine. Their commitment, intellect, and innovative thinking have the power to advance clinical discoveries and improve the way we live.
Corporate Research Agreements and collaborations
While most of our discovery and development programs are developed internally - making ND Pharma quite unique in the industry - we are continuously looking for partnerships and superior technology that complement our business model. Some of our current collaborations include:
- Exclusive licensing agreements with multi-purpose Research Centers and Universities Worldwide, including some of the most prominent in the fields.
- A multi-year alliance with Mayfield Clinic and major providers of Regenerative Research and Treatment in the Stem Cells sector.
- Multiple lines of research opened within different private institutions worldwide where ND Pharma participates within different collaborative ways.
- Our new molecules laboratory develops and investigate within new molecule´s latest developments to give industry and professionals different levels of response and tools to fight against certain conditions and unmet medical and health illnesses from neurology to orthopedics, eye care to vascular disorders o addictions medicine. Between those discoveries appear certain forms of plant-derived new molecules for the treatment of most aggressive conditions.
- Agreements with major industry labs and research organizations to develop solutions for food and nutrition industry in order to achieve one of our motivational goals of removing toxic chemicals from food within the industry.
ND PHARMA is constantly seeking for partnerships and associations in everyone of the fields that we developed and where we conduct business. These partnerships and associations include academic institutions, research centers, other corporations and individuals.
Partnering is a key component of our business strategy, as we consider every possibility to develop and partner successful programs to pharmaceutical, biotechnology and medical device products, services, components and companies.
We welcome enquiries from other companies wishing to discuss any partnering opportunity with us.
In-Licensing is another source of business for us. We welcome contacts from academic institutions, inventors, researchers and other operatori within the industry from biotech, pharma, or other related fields. Our prime filter criteria is based on a three step consideration initial process:
- have strong intellectual property positions;
- address significant unmet medical, health, food, nutrition, or analogue needs, and
- have the potential to enter into development within 12 to 18 months after acquisition or licensing.
Working with corporate partners.
ND PHARMA focuses in developing pioneering and novel products, drugs, and molecules in specialist areas, from food to pharma and therapy where there is a distinct lack of existing solutions, with emphasis in personalized medicine and novel therapies in the field of Regenerative Medicine, Stem Cell Advancement and other like nutrition.
Since our foundation, our research strategy has been to work closely to different "first line" institutions and operational centers that conduct investigation for us, under guidance and supervision of our clinical & scientific director´s team. These institutional cooperation enables us to access innovative research and cutting edge discovery with substantial added value and immediate application to the developments under a relatively optimized costs. ND Pharma maintains exclusive tights to all the intellectual property assets generated under such cooperation agreement and the research and development conducted.
Our market strategy, specially referred to pharmaceutical and therapeutic industry is to license our assets to leading international corporations and/or other industry operators (nutrition, food, feed, etc.) that are interested in further development and commercialization of some molecules and/or drugs.
We offer distinctive solutions to a number of unmet clinical conditions, diseases and pathologies.
Business development and clients.
ND PHARMA entered into some important and interesting corporate deals with major companies worldwide. So some of the "multi-billion dollar" corporations are now within our client list. Specifically within the food and nutrition industry we developed product innovation and license deals with the major producers of drinks, sodas, sport beverages and related industry sectors in the field, helping them to improve the quality, health and nutrition properties of their own products, both existing and other to appear. Other huge market corporations we work for include desert and ice-cream industry, infant nutrition labs and manufacturers, and large corporation of general foods.
ND PHARMA also supply with active principles, transformation and refining of molecules and own developments to pharmaceutical industry including some of the "top ten" Pharma Corporations, with presence all around the world.
Operations.
ND PHARMA operations are conducted worldwide. We are proud of having business partners worldwide and operate in 5 continents.
